These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 29316929)

  • 21. Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria.
    Esu E; Tacoli C; Gai P; Berens-Riha N; Pritsch M; Loescher T; Meremikwu M
    Parasitol Res; 2018 Mar; 117(3):801-807. PubMed ID: 29332155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda.
    Alruwaili M; Uwimana A; Sethi R; Murindahabi M; Piercefield E; Umulisa N; Abram A; Eckert E; Munguti K; Mbituyumuremyi A; Gutman JR; Sullivan DJ
    Am J Trop Med Hyg; 2023 Nov; 109(5):1057-1062. PubMed ID: 37783456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
    Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
    Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India.
    Sharma D; Lather M; Mallick PK; Adak T; Dang AS; Valecha N; Singh OP
    Parasit Vectors; 2015 Sep; 8():471. PubMed ID: 26381498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
    Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
    Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
    Sharma D; Lather M; Dykes CL; Dang AS; Adak T; Singh OP
    Parasitol Res; 2016 Jan; 115(1):323-8. PubMed ID: 26407876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.
    Juma DW; Omondi AA; Ingasia L; Opot B; Cheruiyot A; Yeda R; Okudo C; Cheruiyot J; Muiruri P; Ngalah B; Chebon LJ; Eyase F; Johnson J; Bulimo WD; Akala HM; Andagalu B; Kamau E
    Malar J; 2014 Jul; 13():250. PubMed ID: 24989984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
    Chatterjee M; Ganguly S; Saha P; Guha SK; Maji AK
    Infect Genet Evol; 2017 Sep; 53():155-159. PubMed ID: 28533179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.
    Tahita MC; Tinto H; Erhart A; Kazienga A; Fitzhenry R; VanOvermeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; Van Geertruyden JP; D'Alessandro U
    PLoS One; 2015; 10(9):e0137440. PubMed ID: 26368675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.
    Rosillo SR; Dimbu PR; Cândido ALM; Oh JM; Ferreira CM; Nieto Andrade B; Labuda S; Horth R; Kelley J; Morais JFM; Fortes F; Martins JF; Talundzic E; Pluciński MM
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0160122. PubMed ID: 36916920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
    Sugaram R; Suwannasin K; Kunasol C; Mathema VB; Day NPJ; Sudathip P; Prempree P; Dondorp AM; Imwong M
    Malar J; 2020 Mar; 19(1):107. PubMed ID: 32127009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
    Quan H; Igbasi U; Oyibo W; Omilabu S; Chen SB; Shen HM; Okolie C; Chen JH; Zhou XN
    Infect Dis Poverty; 2020 Jul; 9(1):91. PubMed ID: 32653033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.